

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55309125 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.55309125 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.38782660 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.21487088 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.21487088 |
| 6 | exogenous drug catabolic process (GO:0042738) | 7.19065792 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.93098928 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.82713136 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.40359560 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.20137871 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.20137871 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.20137871 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.09091754 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.97482565 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.83168658 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.77367850 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.69491318 |
| 18 | urea metabolic process (GO:0019627) | 5.68850734 |
| 19 | urea cycle (GO:0000050) | 5.68850734 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.62889040 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62831835 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.49936615 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.43231399 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.41968491 |
| 25 | regulation of plasminogen activation (GO:0010755) | 5.33709842 |
| 26 | drug metabolic process (GO:0017144) | 5.33164528 |
| 27 | cysteine metabolic process (GO:0006534) | 5.31230166 |
| 28 | oxidative demethylation (GO:0070989) | 5.30833459 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.29245644 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.22438657 |
| 31 | bile acid metabolic process (GO:0008206) | 5.11004757 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.10494911 |
| 33 | phenylpropanoid metabolic process (GO:0009698) | 5.09321469 |
| 34 | regulation of complement activation (GO:0030449) | 5.05366435 |
| 35 | * protein carboxylation (GO:0018214) | 5.01420697 |
| 36 | * peptidyl-glutamic acid carboxylation (GO:0017187) | 5.01420697 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.95363565 |
| 38 | ethanol metabolic process (GO:0006067) | 4.94817464 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.93127598 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.92564067 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90976307 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.83352969 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.83352470 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.83352470 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.83352470 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.78376771 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.78124741 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.78124741 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.74140727 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.64937567 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.64937567 |
| 52 | phospholipid efflux (GO:0033700) | 4.64748325 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.63932090 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.62593791 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.62593791 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.59905147 |
| 57 | lysine catabolic process (GO:0006554) | 4.55987692 |
| 58 | lysine metabolic process (GO:0006553) | 4.55987692 |
| 59 | negative regulation of protein activation cascade (GO:2000258) | 4.55720709 |
| 60 | intestinal cholesterol absorption (GO:0030299) | 4.53165666 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.46386676 |
| 62 | acute-phase response (GO:0006953) | 4.45100749 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 4.43937800 |
| 64 | regulation of humoral immune response (GO:0002920) | 4.43212917 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.42797809 |
| 66 | negative regulation of wound healing (GO:0061045) | 4.42577604 |
| 67 | glycine metabolic process (GO:0006544) | 4.40960386 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 4.38795643 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.38761197 |
| 70 | coenzyme catabolic process (GO:0009109) | 4.38227899 |
| 71 | negative regulation of coagulation (GO:0050819) | 4.34850826 |
| 72 | cholesterol efflux (GO:0033344) | 4.30490210 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.30241748 |
| 74 | amine catabolic process (GO:0009310) | 4.30241748 |
| 75 | glutamate metabolic process (GO:0006536) | 4.28007897 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 4.26232483 |
| 77 | cellular glucuronidation (GO:0052695) | 4.25715737 |
| 78 | alkaloid metabolic process (GO:0009820) | 4.22361953 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 4.15833043 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 4.14536792 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.11193076 |
| 82 | ethanol oxidation (GO:0006069) | 4.08386613 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 4.08314449 |
| 84 | fibrinolysis (GO:0042730) | 4.06092391 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 4.05408231 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.05097230 |
| 87 | positive regulation of blood coagulation (GO:0030194) | 4.01830439 |
| 88 | positive regulation of hemostasis (GO:1900048) | 4.01830439 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 4.00199532 |
| 90 | arginine metabolic process (GO:0006525) | 3.99805326 |
| 91 | aldehyde catabolic process (GO:0046185) | 3.95103586 |
| 92 | drug catabolic process (GO:0042737) | 3.94934375 |
| 93 | S-adenosylmethionine metabolic process (GO:0046500) | 3.92482442 |
| 94 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.92116530 |
| 95 | blood coagulation, intrinsic pathway (GO:0007597) | 3.90446463 |
| 96 | ketone body metabolic process (GO:1902224) | 3.86262543 |
| 97 | negative regulation of complement activation (GO:0045916) | 3.84967223 |
| 98 | protein-lipid complex subunit organization (GO:0071825) | 3.84395372 |
| 99 | complement activation, classical pathway (GO:0006958) | 3.82334463 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82076739 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82076739 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81171959 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.79812248 |
| 104 | cofactor catabolic process (GO:0051187) | 3.79426628 |
| 105 | complement activation (GO:0006956) | 3.78414461 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.78130594 |
| 107 | protein activation cascade (GO:0072376) | 3.77452835 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.77439201 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.77439201 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.77123328 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.75865592 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.74601976 |
| 113 | organic acid catabolic process (GO:0016054) | 3.72070299 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 3.72070299 |
| 115 | sterol homeostasis (GO:0055092) | 3.70877578 |
| 116 | cytolysis (GO:0019835) | 3.69881475 |
| 117 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.69307716 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 3.68516912 |
| 119 | proline metabolic process (GO:0006560) | 3.68198209 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 3.67388556 |
| 121 | regulation of lipoprotein particle clearance (GO:0010984) | 3.65914221 |
| 122 | positive regulation of coagulation (GO:0050820) | 3.65878547 |
| 123 | protein-lipid complex assembly (GO:0065005) | 3.65823462 |
| 124 | acetyl-CoA metabolic process (GO:0006084) | 3.64570904 |
| 125 | short-chain fatty acid metabolic process (GO:0046459) | 3.63887124 |
| 126 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.57344263 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.56432692 |
| 128 | opsonization (GO:0008228) | 3.55723016 |
| 129 | steroid catabolic process (GO:0006706) | 3.54770717 |
| 130 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.48761461 |
| 131 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.48761461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41354632 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19368278 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.03407579 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51414686 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32029990 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.10107021 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.77093628 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03973115 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.99622710 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08392710 |
| 11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9107856 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95460544 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91571905 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63375729 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56476703 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50769139 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46646035 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40772180 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33055891 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22676548 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19304847 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17356246 |
| 23 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.08413854 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07813750 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06404668 |
| 26 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00537524 |
| 27 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00319624 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00231034 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00120892 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98424569 |
| 31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96218940 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.93044141 |
| 33 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92952210 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92187782 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91873440 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86560116 |
| 37 | SA1_27219007_Chip-Seq_Bcells_Human | 0.86047446 |
| 38 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84696295 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 0.83608554 |
| 40 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.83399973 |
| 41 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.82844401 |
| 42 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82489231 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82060743 |
| 44 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.81928191 |
| 45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81741119 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80405380 |
| 47 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.79602594 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79347297 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79206592 |
| 50 | ERA_21632823_ChIP-Seq_H3396_Human | 0.78768101 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78325967 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77919667 |
| 53 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.77004215 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75204996 |
| 55 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75022338 |
| 56 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74859292 |
| 57 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74579345 |
| 58 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73325770 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73103800 |
| 60 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.72806105 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.71737417 |
| 62 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.71612260 |
| 63 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.71556917 |
| 64 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.71456496 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70387824 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68466129 |
| 67 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.68403017 |
| 68 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67991189 |
| 69 | * P300_27268052_Chip-Seq_Bcells_Human | 0.67832204 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.67260368 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66586256 |
| 72 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.66331166 |
| 73 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.66331166 |
| 74 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.66199417 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65924840 |
| 76 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.65768633 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65113929 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65113929 |
| 79 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.64680660 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64669810 |
| 81 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.63648972 |
| 82 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62507206 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62426967 |
| 84 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.61876878 |
| 85 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.61301446 |
| 86 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60798883 |
| 87 | * GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.60788162 |
| 88 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60781283 |
| 89 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.59818106 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59733835 |
| 91 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.59013331 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57987180 |
| 93 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57458702 |
| 94 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.56675284 |
| 95 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.56517215 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.56515105 |
| 97 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.55741715 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55670742 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55247156 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.54964623 |
| 101 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.54408447 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53677796 |
| 103 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51786112 |
| 104 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.51166303 |
| 105 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50687013 |
| 106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50456184 |
| 107 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50298643 |
| 108 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49786506 |
| 109 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48391877 |
| 110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47725228 |
| 111 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47671282 |
| 112 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47322804 |
| 113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46603113 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46194981 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44849677 |
| 116 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44622850 |
| 117 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43556005 |
| 118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43459442 |
| 119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.42531768 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42465570 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42206983 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41523014 |
| 123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41487384 |
| 124 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41299828 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41122260 |
| 126 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40868486 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40509598 |
| 128 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.40261639 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40142903 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39852735 |
| 131 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.39375259 |
| 132 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38884234 |
| 133 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38878492 |
| 134 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.38640906 |
| 135 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38394229 |
| 136 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37398912 |
| 137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36370486 |
| 138 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35888227 |
| 139 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34821133 |
| 140 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34008085 |
| 141 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.33348994 |
| 142 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33268233 |
| 143 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.32747356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.34266578 |
| 2 | MP0005360_urolithiasis | 7.57996900 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.46467215 |
| 4 | MP0005365_abnormal_bile_salt | 6.17140184 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.12102755 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.22015881 |
| 7 | MP0003252_abnormal_bile_duct | 3.94622215 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.61753320 |
| 9 | MP0009840_abnormal_foam_cell | 3.29062113 |
| 10 | MP0005083_abnormal_biliary_tract | 3.13020571 |
| 11 | MP0003195_calcinosis | 2.81515254 |
| 12 | MP0005332_abnormal_amino_acid | 2.73225484 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.61295472 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.34077666 |
| 15 | MP0000609_abnormal_liver_physiology | 2.17613778 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.11758351 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.10898372 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.94695801 |
| 19 | MP0003868_abnormal_feces_composition | 1.91016785 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82568435 |
| 21 | MP0001764_abnormal_homeostasis | 1.66001581 |
| 22 | MP0009697_abnormal_copulation | 1.60811346 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56901452 |
| 24 | MP0005451_abnormal_body_composition | 1.41741919 |
| 25 | MP0003011_delayed_dark_adaptation | 1.37126526 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.28544742 |
| 27 | MP0003186_abnormal_redox_activity | 1.21998192 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.21130014 |
| 29 | MP0000566_synostosis | 1.18610082 |
| 30 | MP0000598_abnormal_liver_morphology | 1.17925292 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.13999828 |
| 32 | MP0005647_abnormal_sex_gland | 1.13721160 |
| 33 | MP0000604_amyloidosis | 1.11591708 |
| 34 | MP0009764_decreased_sensitivity_to | 1.07061234 |
| 35 | MP0002254_reproductive_system_inflammat | 1.06657790 |
| 36 | MP0010368_abnormal_lymphatic_system | 0.99550708 |
| 37 | * MP0009763_increased_sensitivity_to | 0.98196313 |
| 38 | MP0003172_abnormal_lysosome_physiology | 0.98138925 |
| 39 | MP0001915_intracranial_hemorrhage | 0.94589552 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 0.91989033 |
| 41 | MP0008469_abnormal_protein_level | 0.90267611 |
| 42 | * MP0009642_abnormal_blood_homeostasis | 0.86504933 |
| 43 | MP0000371_diluted_coat_color | 0.85233434 |
| 44 | MP0005408_hypopigmentation | 0.81554421 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 0.80504882 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 0.79822411 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 0.79612846 |
| 48 | MP0005376_homeostasis/metabolism_phenot | 0.79011750 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.78265723 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.77997073 |
| 51 | MP0002089_abnormal_postnatal_growth/wei | 0.77521677 |
| 52 | MP0005670_abnormal_white_adipose | 0.77516052 |
| 53 | MP0005187_abnormal_penis_morphology | 0.75939557 |
| 54 | MP0005409_darkened_coat_color | 0.73906739 |
| 55 | MP0002971_abnormal_brown_adipose | 0.72533451 |
| 56 | MP0005220_abnormal_exocrine_pancreas | 0.71722146 |
| 57 | MP0004130_abnormal_muscle_cell | 0.70239930 |
| 58 | MP0005334_abnormal_fat_pad | 0.69587477 |
| 59 | MP0003690_abnormal_glial_cell | 0.68742467 |
| 60 | MP0005535_abnormal_body_temperature | 0.67793373 |
| 61 | MP0001661_extended_life_span | 0.66473548 |
| 62 | MP0003329_amyloid_beta_deposits | 0.64523095 |
| 63 | MP0005266_abnormal_metabolism | 0.62992737 |
| 64 | MP0009053_abnormal_anal_canal | 0.62519480 |
| 65 | MP0001324_abnormal_eye_pigmentation | 0.61958509 |
| 66 | MP0000639_abnormal_adrenal_gland | 0.60681647 |
| 67 | MP0001986_abnormal_taste_sensitivity | 0.60270083 |
| 68 | MP0005174_abnormal_tail_pigmentation | 0.58471947 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.57468065 |
| 70 | MP0005448_abnormal_energy_balance | 0.56929921 |
| 71 | MP0001756_abnormal_urination | 0.56778059 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 0.56746697 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 0.56397680 |
| 74 | MP0002822_catalepsy | 0.54745277 |
| 75 | MP0002282_abnormal_trachea_morphology | 0.52636747 |
| 76 | MP0002928_abnormal_bile_duct | 0.48418723 |
| 77 | MP0008874_decreased_physiological_sensi | 0.47493381 |
| 78 | MP0005395_other_phenotype | 0.47211046 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.46646349 |
| 80 | MP0003879_abnormal_hair_cell | 0.46627280 |
| 81 | MP0003436_decreased_susceptibility_to | 0.46179883 |
| 82 | MP0003724_increased_susceptibility_to | 0.44657560 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.44347158 |
| 84 | MP0008873_increased_physiological_sensi | 0.44200133 |
| 85 | MP0003075_altered_response_to | 0.43585387 |
| 86 | MP0003718_maternal_effect | 0.43338727 |
| 87 | MP0005197_abnormal_uvea_morphology | 0.43036058 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.42846745 |
| 89 | MP0004381_abnormal_hair_follicle | 0.40684494 |
| 90 | MP0003953_abnormal_hormone_level | 0.40668903 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 0.40582930 |
| 92 | MP0005166_decreased_susceptibility_to | 0.39951617 |
| 93 | MP0008872_abnormal_physiological_respon | 0.38873700 |
| 94 | MP0003122_maternal_imprinting | 0.38758840 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.38598927 |
| 96 | MP0009672_abnormal_birth_weight | 0.35604298 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.35238483 |
| 98 | MP0006082_CNS_inflammation | 0.35032223 |
| 99 | MP0000579_abnormal_nail_morphology | 0.34461443 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.33297281 |
| 101 | MP0009115_abnormal_fat_cell | 0.32831923 |
| 102 | MP0004883_abnormal_blood_vessel | 0.32698901 |
| 103 | MP0009785_altered_susceptibility_to | 0.32577949 |
| 104 | MP0008007_abnormal_cellular_replicative | 0.32252845 |
| 105 | MP0000249_abnormal_blood_vessel | 0.32250201 |
| 106 | MP0001853_heart_inflammation | 0.32018287 |
| 107 | MP0005023_abnormal_wound_healing | 0.32004249 |
| 108 | MP0002796_impaired_skin_barrier | 0.30386846 |
| 109 | MP0001243_abnormal_dermal_layer | 0.30270990 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.30042301 |
| 111 | MP0002970_abnormal_white_adipose | 0.30001081 |
| 112 | MP0002168_other_aberrant_phenotype | 0.29987241 |
| 113 | MP0005410_abnormal_fertilization | 0.29529111 |
| 114 | MP0001944_abnormal_pancreas_morphology | 0.29492058 |
| 115 | MP0002075_abnormal_coat/hair_pigmentati | 0.29441165 |
| 116 | MP0001845_abnormal_inflammatory_respons | 0.29362447 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.29064211 |
| 118 | MP0001881_abnormal_mammary_gland | 0.28261265 |
| 119 | MP0002132_abnormal_respiratory_system | 0.26013035 |
| 120 | MP0005164_abnormal_response_to | 0.25174160 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.24946203 |
| 122 | MP0002090_abnormal_vision | 0.23518990 |
| 123 | MP0005058_abnormal_lysosome_morphology | 0.22101420 |
| 124 | MP0003950_abnormal_plasma_membrane | 0.20616268 |
| 125 | MP0002092_abnormal_eye_morphology | 0.20382515 |
| 126 | MP0003699_abnormal_female_reproductive | 0.19594182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.51448533 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.35756025 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.34049679 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.68312864 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64792600 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.45880891 |
| 7 | Xanthomatosis (HP:0000991) | 6.29759290 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.57603831 |
| 9 | Complement deficiency (HP:0004431) | 5.47665791 |
| 10 | Joint hemorrhage (HP:0005261) | 4.90105094 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.83198017 |
| 12 | Hyperammonemia (HP:0001987) | 4.57192476 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.55382314 |
| 14 | Epidermoid cyst (HP:0200040) | 4.52431118 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42134671 |
| 16 | Hyperglycinemia (HP:0002154) | 4.41621858 |
| 17 | Ketosis (HP:0001946) | 4.24676762 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.23435301 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21780495 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.21238577 |
| 21 | Fat malabsorption (HP:0002630) | 4.15275018 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11718622 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08178041 |
| 24 | Abnormality of complement system (HP:0005339) | 3.99694266 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.88860526 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88860526 |
| 27 | Hyperglycinuria (HP:0003108) | 3.87256735 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.84769332 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.82183725 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.81093885 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.80901473 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.67191689 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.35891176 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.31047528 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.27132493 |
| 36 | Spontaneous abortion (HP:0005268) | 3.13154095 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.11021206 |
| 38 | Steatorrhea (HP:0002570) | 3.10280289 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04592932 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.03488088 |
| 41 | Hypochromic microcytic anemia (HP:0004840) | 3.02879714 |
| 42 | Myocardial infarction (HP:0001658) | 2.99437408 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.98707536 |
| 44 | Ketoacidosis (HP:0001993) | 2.98412866 |
| 45 | Fair hair (HP:0002286) | 2.91309957 |
| 46 | Skin nodule (HP:0200036) | 2.78601496 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.78469766 |
| 48 | Metabolic acidosis (HP:0001942) | 2.73121102 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.65797536 |
| 50 | Acanthocytosis (HP:0001927) | 2.64920506 |
| 51 | Osteomalacia (HP:0002749) | 2.63228867 |
| 52 | Vascular calcification (HP:0004934) | 2.56410616 |
| 53 | Lethargy (HP:0001254) | 2.55095024 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52344502 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.52344502 |
| 56 | Glomerulonephritis (HP:0000099) | 2.51866642 |
| 57 | Arthropathy (HP:0003040) | 2.51342873 |
| 58 | Purpura (HP:0000979) | 2.50288236 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.49893832 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.47721950 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.47170595 |
| 62 | Mitral stenosis (HP:0001718) | 2.44634653 |
| 63 | Spastic diplegia (HP:0001264) | 2.44226876 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43232218 |
| 65 | Cholelithiasis (HP:0001081) | 2.41834210 |
| 66 | Gout (HP:0001997) | 2.40263218 |
| 67 | Pulmonary embolism (HP:0002204) | 2.36375428 |
| 68 | Cerebral edema (HP:0002181) | 2.35956033 |
| 69 | Amyloidosis (HP:0011034) | 2.35749095 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.34673821 |
| 71 | Cholecystitis (HP:0001082) | 2.34673821 |
| 72 | Neonatal onset (HP:0003623) | 2.34201777 |
| 73 | Irritability (HP:0000737) | 2.33262330 |
| 74 | Gingival bleeding (HP:0000225) | 2.29637792 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.26735898 |
| 76 | Malnutrition (HP:0004395) | 2.25269595 |
| 77 | Menorrhagia (HP:0000132) | 2.20399435 |
| 78 | Esophageal varix (HP:0002040) | 2.20218391 |
| 79 | Sensorimotor neuropathy (HP:0007141) | 2.14346809 |
| 80 | Thrombophlebitis (HP:0004418) | 2.13388184 |
| 81 | Pancreatitis (HP:0001733) | 2.13243596 |
| 82 | Late onset (HP:0003584) | 2.12269811 |
| 83 | Generalized hypopigmentation of hair (HP:0011358) | 2.11703108 |
| 84 | Brushfield spots (HP:0001088) | 2.09769889 |
| 85 | Poikilocytosis (HP:0004447) | 2.09678202 |
| 86 | Enlarged kidneys (HP:0000105) | 2.07195312 |
| 87 | Vomiting (HP:0002013) | 2.03243763 |
| 88 | Hemorrhage of the eye (HP:0011885) | 2.03003537 |
| 89 | Opisthotonus (HP:0002179) | 2.02475594 |
| 90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01493576 |
| 91 | Abnormality of the gallbladder (HP:0005264) | 2.00896631 |
| 92 | Increased serum ferritin (HP:0003281) | 1.98617960 |
| 93 | B lymphocytopenia (HP:0010976) | 1.98613664 |
| 94 | Generalized aminoaciduria (HP:0002909) | 1.97820524 |
| 95 | Hyperphosphaturia (HP:0003109) | 1.96980306 |
| 96 | Widely patent fontanelles and sutures (HP:0004492) | 1.94289255 |
| 97 | Elevated alkaline phosphatase (HP:0003155) | 1.94029998 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 1.93615630 |
| 99 | Neonatal hypoglycemia (HP:0001998) | 1.91207001 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90565075 |
| 101 | Rickets (HP:0002748) | 1.90305769 |
| 102 | Abnormality of the Achilles tendon (HP:0005109) | 1.90177176 |
| 103 | Abnormality of alanine metabolism (HP:0010916) | 1.89737124 |
| 104 | Hyperalaninemia (HP:0003348) | 1.89737124 |
| 105 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.89737124 |
| 106 | Abnormality of urine glucose concentration (HP:0011016) | 1.86393481 |
| 107 | Glycosuria (HP:0003076) | 1.86393481 |
| 108 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85071786 |
| 109 | Hypophosphatemic rickets (HP:0004912) | 1.84334778 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 1.83495592 |
| 111 | Hydroxyprolinuria (HP:0003080) | 1.83495592 |
| 112 | Abnormality of B cell number (HP:0010975) | 1.83315982 |
| 113 | Renal cortical cysts (HP:0000803) | 1.82780728 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 1.82004116 |
| 115 | Status epilepticus (HP:0002133) | 1.81862848 |
| 116 | Elevated hepatic transaminases (HP:0002910) | 1.80660656 |
| 117 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80059686 |
| 118 | Nephritis (HP:0000123) | 1.78275521 |
| 119 | Alkalosis (HP:0001948) | 1.77100462 |
| 120 | Joint swelling (HP:0001386) | 1.76567980 |
| 121 | Epistaxis (HP:0000421) | 1.76260404 |
| 122 | Hyperglycemia (HP:0003074) | 1.73457643 |
| 123 | Reticulocytosis (HP:0001923) | 1.73227323 |
| 124 | Abnormal urine phosphate concentration (HP:0012599) | 1.72402303 |
| 125 | Gangrene (HP:0100758) | 1.67304773 |
| 126 | Increased serum pyruvate (HP:0003542) | 1.63781741 |
| 127 | Bile duct proliferation (HP:0001408) | 1.62713856 |
| 128 | Abnormal biliary tract physiology (HP:0012439) | 1.62713856 |
| 129 | Hypophosphatemia (HP:0002148) | 1.60768242 |
| 130 | Vaginal fistula (HP:0004320) | 1.53223675 |
| 131 | Synostosis involving the elbow (HP:0003938) | 1.50179092 |
| 132 | Humeroradial synostosis (HP:0003041) | 1.50179092 |
| 133 | Back pain (HP:0003418) | 1.49755588 |
| 134 | Hypochromic anemia (HP:0001931) | 1.49560625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.98974604 |
| 2 | FGFR4 | 4.63463468 |
| 3 | SIK1 | 4.57662893 |
| 4 | ERN1 | 4.42427575 |
| 5 | MAP3K9 | 4.30796897 |
| 6 | ARAF | 3.76880781 |
| 7 | TAOK3 | 3.25000232 |
| 8 | INSRR | 2.95681905 |
| 9 | ERBB4 | 2.89186859 |
| 10 | WNK4 | 2.61712763 |
| 11 | NLK | 2.60078788 |
| 12 | MAP2K4 | 2.38668652 |
| 13 | PKN2 | 2.25826580 |
| 14 | MUSK | 2.25274720 |
| 15 | MST1R | 2.07627556 |
| 16 | MAPK11 | 1.91628363 |
| 17 | FLT3 | 1.87643271 |
| 18 | PIK3CG | 1.86604465 |
| 19 | KSR2 | 1.83089836 |
| 20 | TRIB3 | 1.81088141 |
| 21 | TYK2 | 1.76660372 |
| 22 | DAPK2 | 1.75000653 |
| 23 | PRKCI | 1.73036978 |
| 24 | LATS1 | 1.55614098 |
| 25 | PTK6 | 1.48545231 |
| 26 | ABL2 | 1.42594935 |
| 27 | FRK | 1.38987024 |
| 28 | NEK9 | 1.38197805 |
| 29 | FGFR2 | 1.37601525 |
| 30 | KDR | 1.27413784 |
| 31 | JAK2 | 1.26328451 |
| 32 | MAP3K7 | 1.26279379 |
| 33 | GRK6 | 1.16858827 |
| 34 | TYRO3 | 1.13526991 |
| 35 | PRKAA2 | 1.11838942 |
| 36 | MAP3K10 | 1.09573488 |
| 37 | JAK1 | 1.09011286 |
| 38 | PINK1 | 1.08588615 |
| 39 | CSNK1A1L | 1.08429488 |
| 40 | TBK1 | 1.07344366 |
| 41 | MAP2K3 | 1.06409254 |
| 42 | ERBB2 | 1.03574829 |
| 43 | MAP3K14 | 1.02592081 |
| 44 | BRAF | 1.00890816 |
| 45 | MAPK4 | 0.98634469 |
| 46 | PRKCZ | 0.92180789 |
| 47 | RAF1 | 0.90577267 |
| 48 | EPHB1 | 0.85008651 |
| 49 | MAPK12 | 0.81988084 |
| 50 | CDK6 | 0.79777592 |
| 51 | MAP3K3 | 0.79294128 |
| 52 | MAP3K11 | 0.78573456 |
| 53 | MOS | 0.78032288 |
| 54 | NTRK3 | 0.77990661 |
| 55 | EPHA3 | 0.77315808 |
| 56 | TESK2 | 0.77073413 |
| 57 | TIE1 | 0.77064019 |
| 58 | MET | 0.76454746 |
| 59 | CAMK1D | 0.76199128 |
| 60 | PRKACG | 0.75708248 |
| 61 | MAPK15 | 0.75232083 |
| 62 | STK38L | 0.73796909 |
| 63 | CSNK1D | 0.73727775 |
| 64 | DYRK1B | 0.72963150 |
| 65 | CSK | 0.72336767 |
| 66 | CDK12 | 0.71701332 |
| 67 | CAMK2G | 0.69293784 |
| 68 | SGK3 | 0.69218457 |
| 69 | EPHA4 | 0.67977260 |
| 70 | IRAK3 | 0.67105731 |
| 71 | GSK3A | 0.64502361 |
| 72 | PRKAA1 | 0.63580312 |
| 73 | ADRBK2 | 0.63227834 |
| 74 | RIPK1 | 0.62739876 |
| 75 | MAP2K6 | 0.62596751 |
| 76 | FGFR3 | 0.62027806 |
| 77 | CSF1R | 0.61867926 |
| 78 | FGFR1 | 0.59581140 |
| 79 | MAPK7 | 0.58544988 |
| 80 | IKBKE | 0.57868320 |
| 81 | WNK1 | 0.56564547 |
| 82 | PDGFRA | 0.56010781 |
| 83 | PRKCQ | 0.54740446 |
| 84 | TGFBR2 | 0.54375482 |
| 85 | MAP3K13 | 0.53516086 |
| 86 | TNK2 | 0.53137003 |
| 87 | PDPK1 | 0.52652956 |
| 88 | PTK2 | 0.52320754 |
| 89 | SGK2 | 0.51038194 |
| 90 | JAK3 | 0.49906205 |
| 91 | PRKG1 | 0.49356960 |
| 92 | ITK | 0.46417717 |
| 93 | DYRK1A | 0.45880752 |
| 94 | PRKACA | 0.45261450 |
| 95 | RET | 0.44762582 |
| 96 | CSNK1G1 | 0.44473076 |
| 97 | TAOK2 | 0.43649905 |
| 98 | IGF1R | 0.43421551 |
| 99 | GRK1 | 0.42687123 |
| 100 | MAP3K5 | 0.42310302 |
| 101 | PRKCG | 0.42210974 |
| 102 | MAP2K1 | 0.41733387 |
| 103 | AKT3 | 0.40682851 |
| 104 | SYK | 0.40153454 |
| 105 | PKN1 | 0.39790494 |
| 106 | CDK4 | 0.39767767 |
| 107 | ZAK | 0.39714282 |
| 108 | LCK | 0.38832503 |
| 109 | SGK1 | 0.38277893 |
| 110 | ZAP70 | 0.37414889 |
| 111 | MAPK3 | 0.36869521 |
| 112 | MAP3K1 | 0.36643051 |
| 113 | CSNK1E | 0.36623748 |
| 114 | ICK | 0.35734619 |
| 115 | PDK1 | 0.35413710 |
| 116 | CAMK4 | 0.34806789 |
| 117 | EGFR | 0.34664988 |
| 118 | SRC | 0.34449253 |
| 119 | SGK223 | 0.34058608 |
| 120 | SGK494 | 0.34058608 |
| 121 | MAPK8 | 0.33829457 |
| 122 | MTOR | 0.33662618 |
| 123 | MAP3K6 | 0.32145666 |
| 124 | RPS6KA3 | 0.31039633 |
| 125 | CAMK1G | 0.30990549 |
| 126 | ACVR1B | 0.29409906 |
| 127 | CSNK1A1 | 0.27534041 |
| 128 | MAPK1 | 0.26501011 |
| 129 | PRKCA | 0.26236716 |
| 130 | CSNK1G2 | 0.25960679 |
| 131 | PRKCB | 0.25443267 |
| 132 | MAP4K1 | 0.23457020 |
| 133 | IRAK1 | 0.23110586 |
| 134 | ABL1 | 0.22502864 |
| 135 | PIK3CA | 0.21363348 |
| 136 | PAK3 | 0.20713831 |
| 137 | KIT | 0.20526292 |
| 138 | PBK | 0.20388238 |
| 139 | IRAK2 | 0.19860768 |
| 140 | BMX | 0.19540773 |
| 141 | CSNK1G3 | 0.19538592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55056155 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65445547 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39003241 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36305463 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08568948 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.82570158 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69827436 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69478276 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62594438 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53644789 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47980991 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36344293 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24825401 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15275736 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13592932 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06525599 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94629044 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92975048 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91848308 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91162321 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90269201 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86310584 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80999260 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79355623 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77268440 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74796518 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74787478 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70590409 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70096407 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64871757 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59551858 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57894308 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54640906 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.51131058 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49431697 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46792301 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43316863 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34614628 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32446207 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30345185 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30147048 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28174922 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.22487430 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19383019 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18752344 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18571766 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17987742 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10554585 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02466347 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02103635 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99364752 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97858645 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96930027 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94505031 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93910382 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87106030 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86541456 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85856594 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81560098 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75101152 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68912298 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67528887 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62586169 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55041391 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53254062 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44472902 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44470628 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43842023 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.37327309 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26352375 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25139077 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24392278 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.24282784 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22684067 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21936921 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19891210 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16560368 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15713333 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10840555 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.09184164 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01733426 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.00657039 |
| 83 | Pertussis_Homo sapiens_hsa05133 | -0.2448469 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2352255 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2348659 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2346915 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2054421 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2047686 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1901953 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1885251 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1871863 |
| 92 | Lysosome_Homo sapiens_hsa04142 | -0.1751189 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1706588 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1698898 |
| 95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1616679 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1515269 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1502335 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1427092 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1413590 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1359102 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1236431 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0928493 |
| 103 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0908856 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0892387 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0703617 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0675484 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0663475 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0457828 |
| 109 | Primary immunodeficiency_Homo sapiens_hsa05340 | -0.0248904 |

